Barbara Rolfe

Title: Barbara Rolfe: Innovator in Hematopoietic Stem Cell Mobilization

Introduction

Barbara Rolfe is a distinguished inventor based in Holland Park West, Australia. She has made significant contributions to the field of hematopoietic stem cell research. Her innovative work focuses on enhancing the mobilization and differentiation of leukocyte populations, which play a crucial role in cancer treatment.

Latest Patents

Barbara Rolfe holds a patent titled "Mobilizing agents and uses therefor." This invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells. The methods and compositions developed by Rolfe aim to stimulate or enhance the development, mobilization, proliferation, and differentiation of neutrophil-containing leukocyte populations. These advancements are essential for inhibiting the growth and spread of tumors and for treating or preventing hyperproliferative cell disorders. She has 1 patent to her name.

Career Highlights

Barbara Rolfe is affiliated with The University of Queensland, where she continues her research and development in the field of stem cell mobilization. Her work has garnered attention for its potential applications in cancer therapy and regenerative medicine.

Collaborations

Barbara collaborates with Trent Martin Woodruff, contributing to the advancement of their shared research interests. Their partnership enhances the scope and impact of their work in the scientific community.

Conclusion

Barbara Rolfe is a pioneering inventor whose work in hematopoietic stem cell mobilization holds promise for improving cancer treatment outcomes. Her contributions to the field are invaluable and continue to inspire future innovations.